More of us
ian Wilmut, the scientist who created Dolly, the world's first mammal cloned from an adult cell has struck a million-dollar deal with a us company to work on human cloning. According to a report in the London Daily Telegraph , Wilmut had agreed to help develop techniques to clone a patient's own cells for transplant, which could provide treatment for a wide range of degenerative diseases.
The project is a collaboration between the Roslin Institute, near Edinburgh, where Dolly was cloned in 1997, and the Californian-based company Geron. Wilmut will receive 83,000 shares of Geron, each worth us $12.
The report said that the new research will have many applications including insulin-producing cells to treat diabetes, nerve cells for stroke, Parkinson's disease and Alzheimer's patients, muscle cells to treat heart attacks and liver cells for the treatment of hepatitis. Producing tissue and cells for transplant will require the cloning of early human embryos, Wilmut said.
Related Content
- First food: business of taste
- State of the Climate in Asia 2024
- Order of the National Green Tribunal regarding large scale felling of toddy yielding palm trees in Bihar, 05/06/2025
- Sub-Saharan Africa’s Economic Outlook 2025: Navigating Uncertainty and Aligning Policy for Sustainable Recovery
- Global Assessment Report on Disaster Risk Reduction 2025
- Order of the National Green Tribunal on the demarcation of Nahargarh Wildlife Sanctuary, Jaipur, Rajasthan, 27/05/2025